UBD upregulation is correlated with increased tumor size, more advanced disease stages, increased recurrence, and decreased survival in colorectal cancer patients, possibly via the degradation of p53 and the promotion of cell proliferation (72, 73). Here, TP53 is linked to colorectal cancer.